MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B5727 PD 334581Summary: MEK1 inhibitor -
C5850 SD 169Summary: selective ATP competitive inhibitor of the MAP kinases p38α and p38β -
C5316 RWJ 67657Summary: orally active inhibitor of the MAP kinases p38α and p38β -
B7736 ML 786 dihydrochlorideSummary: Raf kinase inhibitor -
B5126 10Z-HymenialdisineSummary: Pan kinase inhibitor -
B3261 RO4987655Summary: MEK inhibitor -
C4949 SB 202474Summary: a negative control in studies of p38 inhibition -
B7307 L-779,450Summary: Raf kinase inhibitor -
B1621 TAK-733Target: MEKSummary: MEK allosteric site inhibitor -
B6177 PLX7904Summary: paradox-breaker RAF inhibitor, potent and selective
